BridgeBio Pharma (BBIO) came out with a quarterly loss of 1.02pershareversustheZacksConsensusEstimateofalossof1.09. This compares to loss of 0.98pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof6.420.40 per share when it actually produced a loss of $0.05, delivering a surprise of 87.50%.Over the last four quarters, the ...